Treace Medical Concepts (TMCI) Net Shares Issued and Repurchased (2020 - 2025)

Treace Medical Concepts (TMCI) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $649702.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Net Shares Issued and Repurchased rose 94.31% year-over-year to $649702.0; the trailing twelve-month figure through Dec 2025 stood at $649702.0 (up 94.31% YoY), and the FY2025 full-year result was $649702.0, up 94.31% from the prior year.
• Net Shares Issued and Repurchased advanced to $649702.0 in Q4 2025 per TMCI's latest filing, from $619400.0 in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $963800.0 in Q1 2022 and bottomed at $18030.0 in Q4 2022.
• Historically, Net Shares Issued and Repurchased has averaged $529491.5 across 5 years, with a median of $619400.0 in 2024.
• The sharpest annual moves came in 2021 and 2023: Net Shares Issued and Repurchased soared 4835.52% in 2021, then declined 24.5% in 2023.
• Over 5 years, Net Shares Issued and Repurchased stood at $415125.0 in 2021, then plunged by 95.66% to $18030.0 in 2022, then surged by 463.63% to $101623.0 in 2023, then soared by 229.03% to $334367.0 in 2024, then soared by 94.31% to $649702.0 in 2025.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $649702.0, $619400.0, and $334367.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.